Immunopathogenesis of hepatitis C virus infection and hepatic fibrosis: New insights into antifibrotic therapy in chronic hepatitis C

Keyphrases

• Fibrosis 100%
• Cirrhosis 100%
• Hepatic Fibrosis 100%
• Antifibrotic 100%
• Chronic Hepatitis C 100%
• Hepatitis C Virus Infection 100%
• Immunopathogenesis 100%
• Hepatitis C Virus 66%
• Acute Hepatitis C 66%
• Liver Transplantation 33%
• Ribavirin 33%
• Type I Collagen 33%
• Apoptosis 33%
• Oxidative Stress 33%
• High Risk 33%
• Pathophysiology 33%
• Extracellular Matrix 33%
• Hepatitis C 33%
• Genetic Markers 33%
• Liver Fibrosis 33%
• Hepatic Stellate Cell Activation 33%
• Fibrogenic 33%
• Limited Treatment Options 33%
• Infected Cells 33%
• Pegylated Interferon 33%
• Intolerance 33%
• Fibrogenesis 33%
• High Density 33%
• Virus Diseases 33%
• Wound Healing Response 33%
• Space of Disse 33%
• Fibrosis Progression 33%
• Chronic Liver Injury 33%
• Hepatic Disease 33%

Medicine and Dentistry

• Hepatitis C Virus 100%
• Hepatitis C 100%
• Fibrosis 100%
• Liver Fibrosis 100%
• Chronic Hepatitis C 100%
• Immunopathogenesis 100%
• Liver Cirrhosis 75%
• Injury 50%
• Fibrogenesis 50%
• Ribavirin 25%
• Liver Transplantation 25%
• Programmed Cell Death 25%
• Pathophysiology 25%
• Extracellular Matrix 25%
• Side Effect 25%
• Cell Activation 25%
• Oxidative Stress 25%
• Liver Injury 25%
• Liver Disease 25%
• Virus Infection 25%
• Hepatic Stellate Cell 25%
• Collagen Type 1 25%
• Wound Healing 25%
• Peginterferon 25%
• Genetic Marker 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Fibrosis 100%
• Liver Fibrosis 100%
• Hepatitis C 100%
• Chronic Hepatitis C 100%
• Hepatitis C Virus 100%
• Immunopathogenesis 100%
• Liver Cirrhosis 75%
• Injury 50%
• Liver Injury 25%
• Pathophysiology 25%
• Side Effect 25%
• Liver Disease 25%
• Virus Infection 25%
• Collagen Type 1 25%
• Wound Healing 25%
• Ribavirin 25%
• Peginterferon 25%